Eloisa Torchia
Papers
2
Total Citations
4
H-Index
2
About
Dr. Eloisa Torchia is pioneering the integration of biomimetic cell culture with high-throughput screening (HTS), a critical bottleneck in early-stage drug discovery. Her research centers on developing automated fabrication methods for hydrogel-based cell culture platforms that replicate physiological tissue environments while maintaining the scalability required for industrial drug testing. Dr. Torchia’s major contribution is the HYDRA system (HYDrogels by Robotic liquid handling Automation), which uses robotic liquid handling to precisely deposit hydrogel coatings in standard HTS plates, overcoming the persistent problem of curved menisci that disrupt uniform cell distribution and assay reproducibility. Her foundational papers, “HYDRA” (2024) and its 2025 follow-up, each with 2 citations, establish a novel workflow that marries the biological relevance of organoids and organs-on-chip with the throughput demands of pharmaceutical screening. This work directly addresses the industry’s need for predictive, scalable models, positioning Dr. Torchia as a key innovator at the intersection of biomaterials, automation, and drug development. Her achievements promise to accelerate the translation of preclinical discoveries into effective therapies.
Research Focus
Key Achievements
Top Papers
- 1
- 2